These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 8991899
21. Is hormone replacement therapy cardioprotective? Decision-making after the heart and estrogen/progestin replacement study. McPherson R. Can J Cardiol; 2000 Jan; 16 Suppl A():14A-9A. PubMed ID: 10653926 [Abstract] [Full Text] [Related]
22. [Hormone replacement therapy of menopause, heart and blood vessels]. Kuttenn F, Gerson M. Arch Mal Coeur Vaiss; 2001 Jul; 94(7):685-9. PubMed ID: 11494629 [Abstract] [Full Text] [Related]
23. [Cardiovascular disease as a current threat of older women. Relation to estrogens]. Zárate A, Saucedo R, Basurto L, Martínez C. Ginecol Obstet Mex; 2007 May; 75(5):286-92. PubMed ID: 17849811 [Abstract] [Full Text] [Related]
24. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women]. da Silva PM. Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165 [Abstract] [Full Text] [Related]
25. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action. Brinton RD. Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751 [Abstract] [Full Text] [Related]
26. [Hormone replacement in postmenopausal women with coronary heart disease. Results and clinical consequences from recent studies]. Schurz RA, Benzer W. Wien Klin Wochenschr; 1997 Jun; 109 Suppl 2():42-5. PubMed ID: 9340923 [Abstract] [Full Text] [Related]
27. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women. Alexandersen P, Tankó LB, Bagger YZ, Qin G, Christiansen C. Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657 [Abstract] [Full Text] [Related]
28. [Cardiovascular risk after menopause]. Grand A. Ann Cardiol Angeiol (Paris); 1992 Mar; 41(3):151-61. PubMed ID: 1610097 [Abstract] [Full Text] [Related]
30. Sex hormones and the cardiovascular system: effects on arterial function in women. Teede HJ. Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):672-6. PubMed ID: 17581228 [Abstract] [Full Text] [Related]
31. [Should all menopausal women have hormone replacement therapy for the prevention of coronary disease?]. Neves-e-Castro M. Rev Port Cardiol; 1999 Nov; 18(11):1039-43. PubMed ID: 10608164 [Abstract] [Full Text] [Related]
32. The rationale for a wider range of progestogens. Skouby SO. Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382 [Abstract] [Full Text] [Related]
33. [Hormone replacement therapy and cardiovascular risk in postmenopausal women]. Kovacev-Zavisić B, Icin T, Kovacev N. Med Pregl; 2009 Dec; 62 Suppl 3():85-90. PubMed ID: 19702123 [Abstract] [Full Text] [Related]
35. Rationale for use of lower estrogen doses for postmenopausal hormone therapy. Ettinger B. Maturitas; 2007 May 20; 57(1):81-4. PubMed ID: 17383126 [Abstract] [Full Text] [Related]
36. Cardiovascular health and the menopause: the gynecologist as the patients' interface. Arias RD. Climacteric; 2006 Sep 20; 9 Suppl 1():6-12. PubMed ID: 16899438 [Abstract] [Full Text] [Related]
37. [Hormone replacement therapy and cardiovascular pathology in menopause]. Micheli S, Marcucci R, Farsi A, Abbate R. Ann Ital Med Int; 1998 Sep 20; 13(1):37-46. PubMed ID: 9642841 [Abstract] [Full Text] [Related]
38. Can menopause be considered an independent risk factor for cardiovascular disease? Mercuro G, Zoncu S, Cherchi A, Rosano GM. Ital Heart J; 2001 Oct 20; 2(10):719-27. PubMed ID: 11721715 [Abstract] [Full Text] [Related]